Your session is about to expire
← Back to Search
Educational Intervention for Cancer Knowledge
Study Summary
This trial studies a web-based cancer education tool called HOPE-Genomics. The tool provides patients with information about genomic testing and their own genomic test results. The goal is to improve patient's genomic knowledge and quality of patient-centered care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with lung, breast, colorectal, pancreatic, ovarian, or prostate cancer.My cancer has been genetically sequenced.I am able to care for myself and perform daily activities.I am 18 years old or older.I am unable to understand and give consent for treatment.
- Group 1: Arm I (usual care)
- Group 2: Arm II (genomics test results, HOPE-Genomics)
- Group 3: Arm III (HOPE-Genomics, genomics test results)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently engaged in this research?
"Affirmative, the information posted on clinicaltrials.gov shows that this experiment is actively enrolling participants as of now. It was first uploaded December 30th 2021 and last revised February 11th 2022 to seek 435 subjects from 1 site."
Are there any available openings for participation in this trial?
"Affirmative, the information provided on clinicaltrials.gov denotes that this trial is actively enlisting patients as of now. The study was first published on December 30th 2021 and updated recently on February 11th 2022, with a target enrollment goal of 435 subjects from 1 site."
Share this study with friends
Copy Link
Messenger